Project Details
Projekt Print View

Molecular and multiscale modelling of the dissolution of active pharmaceutical ingredients

Subject Area Theoretical Chemistry: Electronic Structure, Dynamics, Simulation
Chemical and Thermal Process Engineering
Term from 2011 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 210064482
 
Final Report Year 2022

Final Report Abstract

The bioavailability of the active pharmaceutical ingredients (APIs) is governed by the dissolution properties of the drug. Predicting the dissolution properties of a new drug candidate within the human body long before entering the clinical phase is an important step in lowering the cost and shortening the time of drug development. Therefore, this project aims at a protocol for the prediction of dissolution rates of APIs that supports decisions already during in-silico drug development. The predictions of the multiscale approach are based on molecular structure and on crystal packaging. In case the latter is not available, in silico predictions about the crystal packing of single-component, as well as co-crystals can be made by means of computationally cheap, yet accurate atomistic models obtained from the developed ML approach. The dissolution is first investigated in a MD framework. The dissolution of a three-dimensional crystal with real habit is simulated on MD time scale. Sticky dummy atom are introduced into the simulation box to guarantee constant undersaturation. Then, rate constants for the kMC-simulations are obtained from the MD trajectories. For this purpose, molecules belonging to the crystal are classified into different edge or face categories and rate constants are calculated for each face/edge type by counting the corresponding transition events as well as the possibilities for these transitions to occur. Length and time scales of kMC simulations are significantly extended compared to the MD simulations, thus crystal face displacement velocities can be calculated. In a next step, continuum simulations predict the dissolution rates of the API on a macroscopic level. The face displacement rates of the kMC simulations are used as face-specific boundary conditions and the equations of mass transport are solved numerically. However, a sensitivity analysis for all parameters describing the dissolution shows, that e.g. for aspirin the dissolution in stagnant water is strongly diffusion limited and therefore almost insensitive to the dissolution rates. If the dissolution occurs in a flow, such as the drug-delivery in the human body, the diffusion limitation is overcome. With a Mach-Zehnder interferometer setup with an integrated flow cell, it was shown that the extent of the diffusion zone at the surface directed to the flow decreases with increasing inflow velocity and the dissolution rate increases. Thus, in this setup, the diffusion limitation can be overcome, allowing the validation of the kMC displacement rates. The elaborated procedure was successfully tested on the dissolution of an aspirin crystal in stagnant water, where the simulation result are in good agreement with experimental data. MD simulations of the dissolution of the 1:1 co-crystal paracetamol : oxalic acid and of the influence of salts on the growth of a-glycine, respectively, show that the method is also applicable to multicomponent like APIs with hydrates, salts and co-crystals, which are intended to improve solubility.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung